Palvella Therapeutics, Inc.
USD152.50
-2.33 (-1.51%)
CEO
Wesley H. Kaupinen
IPO Date
2015-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$158.19
Prev. Close
$154.84
Day Low
$147.47
Day High
$161.38
52W Low
$21.55
52W High
$161.38
Market Cap
$1.81B
Volume
0.17M
| -1.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -481.7% | 247.6% | 0.00 | 3.20 | 1.2 |
| 31 Dec 2022 | FY | 89.3% | -128.5% | 143.6% | -201.4% | 0.00 | 2.86 | -0.5 |
| 31 Dec 2021 | FY | 92.5% | -145.6% | -90.1% | -29.8% | 0.29 | 2.52 | -0.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.55 | 3.42 | 0.0 |
| -23.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -29.3% | -16.9% | 0.41 | 6.49 | -15.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -19.8% | -12.8% | 0.30 | 7.67 | -6.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -14.7% | -10.3% | 0.00 | 8.84 | -1.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -6.3% | -4.5% | 0.00 | 7.33 | -1.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -41.6% | -33.0% | 0.00 | 4.82 | -0.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -22.3% | -16.7% | 0.00 | 3.95 | -1.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 40.4% | -39.7% | 0.00 | 2.34 | -2.1 |
| 31 Dec 2023 | Q4 | 100.0% | -352.9% | -17.1% | -11.9% | 0.00 | 3.24 | -1.1 |